Global menu

Our global pages

Close

Conditions for the admissibility of scientific research in biomedicine Biobanks: a challenge in times of Big Data

I International Forum on Personalised Medicine 
The First International Forum on Personalised Medicine will take place on the 2 March 2016 in Warsaw. It is the first project of this magnitude that will gather in one place and time representatives of medical science, pharmaceutical industry, manufacturers of diagnostic equipment, professional and regional associations, as well as politicians and scientists who are interested in the development of personalised medicine in Poland and across the world. The event will be attended by Marta Goląb Gadomska and Gerard Karp.

Discussed issues will include, among others:
• the place of personalised medicine in the development of medical sciences
• personalised medicine in clinical practice
• interdisciplinarity in personalised medicine
• ethical conditions and legal environment for the functioning of personalised medicine
• financial and organisational challenges for the health care system using the personalised medicine solutions. 

The last item of the forum will be the declaration of the Polish Coalition of Personalised Medicine. The document will be presented by prof. Jacek Fijuth, Chairman of the Polish Society of Oncology. Wierzbowski Eversheds is a founding member of the Coalition.

During the forum the book "Personalised Medicine. Myths, facts, recommendation", edited by Adam Fronczak, will have its premiere. The authors of the chapter "Legal Environment for personalised medicine - chosen aspects" are Marta Gadomska-Gołąb and Gerard Karp.

Event is organised by the Institute for Health Protection, Employers Union of Innovative Pharmaceutical Companies - INFARMA and the Association for Good Clinical Trials Practice in Poland - GCPpl

Honorary patron of the forum is the Health Ministry.

More information>  http://www.medycynapersonalizowana.pl

On the 8 of June a conference titled  “Conditions for the admissibility of scientific research in biomedicine Biobanks: a challenge in times of Big Data” will be held in Warsaw. The event is organised by the Ministry of Science and Higher Education in cooperation with the Faculty of Law and Administration and the National Contact Point for EU Research Programmes.

During the conference issues concerning: biobanks as an innovative tool for the development of biomedicine, legal regulations concerning data, European experience and recommendations will be discussed.

The group of speakers will include Dr Arwid Mednis who will give a presentation titled “Protection of genetic data in the Polish law”.

See the program of the event

Print Friendly and PDF

© Eversheds Sutherland 2022. All rights reserved. Eversheds Sutherland is a global provider of legal and other services operating through various separate and distinct legal entities.

Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed and affiliated firms and the members of Eversheds Sutherland (Europe) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements and operate in accordance with their locally registered names. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global LLP. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client.